Abstract
P311 was first identified by the group of Studler et al. (1993) in the developing brain. In healthy, but mainly in pathological tissues, P311 is implicated in cell migration and proliferation. Furthermore, evidence in models of tissue fibrosis points to the colocalization with and the stimulation of transforming growth factor β1 by P311. This review provides a comprehensive overview on P311 and discusses its potential as an anti-fibrotic target.
Author supplied keywords
Cite
CITATION STYLE
Stradiot, L., Mannaerts, I., & Van Grunsven, L. A. (2018, October 12). P311, friend, or foe of tissue fibrosis? Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2018.01151
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.